“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
In light of the COVID-19 pandemic, there has been a focus on the shortage of doctors opting to specialize in infectious disease. According to forecasts by the U.S. Health Resources and Services Administration (HRSA), the United States will face a serious shortage of infectious disease doctors with estimates showing that that by 2035 there will […]
Attorneys familiar with vaccine injury claims have described the current compensation program for COVID-19 vaccines as a legal “black hole” and inadequate for addressing the vaccine injury claims associated with the fast-tracked COVID vaccines.1 Attorney Altom Maglio says he has been contacted by hundreds of people who suspect they have suffered COVID vaccine-related injuries but […]
Opinion | The Countermeasures Injury Compensation Program (CICP) is a program of the U.S. government that provide financial compensation for people who have suffered serious injuries or death from vaccines, biologics, antivirals or other drugs, as well medical devices used to “diagnose, prevent or treat a declared pandemic, epidemic or security threat.” The program was […]
On Aug. 23, 2021, the U.S. Food and Drug Administration (FDA) gave full approval to a Biologics License Application (BLA) submitted by BioNTech Manufacturing GmbH of Mainz, Germany on May 18, 2021 for a biologic drug called COVID Vaccine, mRNA. The FDA gave permission to BioNTech to label the product “Comirnaty” and market it in […]
At the height of the fear and confusion associated with the declaration of a coronavirus pandemic public health emergency and strict social distancing regulations in the spring of 2020, U.S. health officials published a report that, in 2016, autism spectrum disorder (ASD) was estimated to affect one in 54 eight-year old children in the U.S., […]
Opinion | The experimental COVID-19 vaccines are being released first to a designated group of health care workers and residents of senior living facilities. As more of the vaccines becomes available, people at high-risk to the SARS-CoV-2 virus due to their medical conditions will be given an opportunity to get vaccines. Finally, the general public […]
Story Highlights Most countries that have supply contracts with AstraZeneca have granted the drug company liability protection for their COVID-19 vaccine. In the U.S., vaccine manufacturers and administrators are shielded from liability under the PREP Act of 2005 for a vaccine or drug that is developed in response to a declared public health emergency, including […]